Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA)

References

• Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med. 12:9.
   Google Scholar
• Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet. 34:263–264.
   PubMed Web of Science ®Google Scholar
• Cekaite L, Furset G, Hovig E, Sioud M. 2007. Gene expression analysis in blood cells in response to unmodified and 2′-modified siRNAs reveals TLR-dependent and independent effects. J Mol Biol. 1:90–108.
   Web of Science ®Google Scholar
• Chiu YL, Rana TM. 2002. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol Cell. 10:549–561.
   PubMed Web of Science ®Google Scholar
• Czauderna F, Fechtner M, Dames S, Ayguèn H, Klippel A, Pronk GJ, Giese K, Kaufmann J. 2003. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31:2705–2716.
   PubMed Web of Science ®Google Scholar
• Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303:1529–1531.
   PubMed Web of Science ®Google Scholar
• Diebold SS, Massacrier C, Akira S, Paturel C, Morel Y, Reis e Sousa C. 2006. Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol. 36:3256–3267.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494–498.
   PubMed Web of Science ®Google Scholar
• García-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science. 312:879–882.
   PubMed Web of Science ®Google Scholar
• Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME. 2004. Lack of interferon response in animals to naked siRNAs. Nat Biotechnol. 22:1579–1582.
   PubMed Web of Science ®Google Scholar
• Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303:1526–1529.
   PubMed Web of Science ®Google Scholar
• Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. 2002. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30:1757–1766.
   PubMed Web of Science ®Google Scholar
• Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T. 2005. Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction. Nature. 434:1035–1040.
   PubMed Web of Science ®Google Scholar
• Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, et al. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science. 314:994–997.
   PubMed Web of Science ®Google Scholar
• Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, et al. 2005. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 11:263–270.
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Akira S. 2005. Innate immune recognition of nucleic acids: beyond toll‐like receptors. Int J Cancer. 117:517–523.
   PubMed Web of Science ®Google Scholar
• Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K, et al. 2002. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med. 11:1507–1512.
   Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 5:987–995.
   PubMed Web of Science ®Google Scholar
• Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, et al. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 21:635–637.
   PubMed Web of Science ®Google Scholar
• Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, Lim L, Linsley PS. 2006. Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA. 12:1179–1187.
   Google Scholar
• Jackson AL, Linsley PS. 2010. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov. 9:57–67.
   PubMed Web of Science ®Google Scholar
• Judge A, MacLachlan I. 2008. Overcoming the innate immune response to small interfering RNA. Hum Gene Ther. 2:13.
   Google Scholar
• Judge AD, Bola G, Lee AC, Maclachlan I. 2006. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther. 13:494–505.
   PubMed Web of Science ®Google Scholar
• Judge AD, Sood V, Shaw JR, Fang D, Mcclintock K, Maclachlan I. 2005. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol. 23:457–462.
   PubMed Web of Science ®Google Scholar
• Kariin S, Burge C. 1995. Dinucleotide relative abundance extremes: a genomic signature. Trends Genet. 11:283–290.
   PubMed Web of Science ®Google Scholar
• Karikó K, Bhuyan P, Capodici J, Weissman D. 2004a. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol. 172:6545–6549.
   PubMed Web of Science ®Google Scholar
• Karikó K, Buckstein M, Ni H, Weissman D. 2005. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 23:165–175.
   PubMed Web of Science ®Google Scholar
• Karikó K, Ni H, Capodici J, Lamphier M, Weissman D. 2004b. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 279: 12542–12550.
   PubMed Web of Science ®Google Scholar
• Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity. 23:19–28.
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 7089:101–105.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 11:373–384.
   PubMed Web of Science ®Google Scholar
• Kim DH, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ. 2004. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol. 22:321–325.
   PubMed Web of Science ®Google Scholar
• Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, et al. 2008. Sequence-and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 452:591–597.
   PubMed Web of Science ®Google Scholar
• Koshkin AA, Singh SK, Nielsen P, Rajwanshi VK, Kumar R, Meldgaard M, Olsen CE, Wengel J. 1998. LNA (Locked Nucleic Acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron. 54:3607–3630.
   Web of Science ®Google Scholar
• Koski GK, Karikó K, Xu S, Weissman D, Cohen PA, Czerniecki BJ. 2004. Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol. 172:3989–3993.
   PubMed Web of Science ®Google Scholar
• Li S, Peters GA, Ding K, Zhang X, Qin J, Sen GC. 2006. Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci USA 103:10005–10010.
   PubMed Web of Science ®Google Scholar
• Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, et al. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 305:1437–1441.
   PubMed Web of Science ®Google Scholar
• Liu YJ. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 23:275–306.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Shotorbani SS, Baradaran, B. 2014. RNA interference and its role in cancer therapy. Adv Pharm Bull. 4:313–321.
   PubMedGoogle Scholar
• Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R, et al. 2006. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol. 24:559–565.
   PubMed Web of Science ®Google Scholar
• Marques JT, Williams BR. 2005. Activation of the mammalian immune system by siRNAs. Nat Biotechnol. 23:1399–1405.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat Rev Immunol. 1:135–145.
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA. 2002. Decoding the patterns of self and nonself by the innate immune system. Science. 296:298–300.
   PubMed Web of Science ®Google Scholar
• Meister G, Tuschl T. 2004. Mechanisms of gene silencing by double-stranded RNA. Nature. 431:343–349.
   PubMed Web of Science ®Google Scholar
• Meurs E, Chong K, Galabru J, Thomas NSB, Kerr IM, Williams BR, Hovanessian AG. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:379–390.
   PubMed Web of Science ®Google Scholar
• Minks MA, West DK, Benvin S, Baglioni C. 1979. Structural requirements of double-stranded RNA for the activation of 2′,5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J Biol Chem. 254:10180–10183.
   PubMed Web of Science ®Google Scholar
• Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, et al. 2005. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol. 23:1002–1007.
   PubMed Web of Science ®Google Scholar
• Persengiev SP, Zhu X, Green MR. 2004. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA. 10:12–18.
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science. 314:997–1001.
   PubMed Web of Science ®Google Scholar
• Puthenveetil S, Whitby L, Ren J, Kelnar K, Krebs JF, Beal PA. 2006. Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification. Nucleic Acids Res. 34:4900–4911.
   PubMed Web of Science ®Google Scholar
• Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, et al. 2006. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA. 12:988–993.
   PubMed Web of Science ®Google Scholar
• Rossi M, Young JW. 2005. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol. 175:1373–1381.
   PubMed Web of Science ®Google Scholar
• Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, Wagner H, Bauer S. 2004. Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐and pH‐dependent manner. Eur J Immunol. 34:2541–2550.
   PubMed Web of Science ®Google Scholar
• Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 4:9.
   Google Scholar
• Saunders LR, Barber GN. 2003. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17:961–983.
   PubMed Web of Science ®Google Scholar
• Scheel B, Teufel R, Probst J, Carralot JP, Geginat J, Radsak M, et al. 2005. Toll‐like receptor‐dependent activation of several human blood cell types by protamine‐condensed mRNA. Eur J Immunol. 35:1557–1566.
   PubMed Web of Science ®Google Scholar
• Schlee M, Hornung V, Hartmann G. 2006. siRNA and isRNA: two edges of one sword. Mol Ther. 14:463–470.
   PubMed Web of Science ®Google Scholar
• Sen G, Flora M, Chattopadhyay G, Klinman DM, Lees A, Mond JJ, Snapper CM. 2004. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity. Cell Immunol. 232:64–74.
   PubMed Web of Science ®Google Scholar
• Sioud M. 2005. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol. 348:1079–1090.
   PubMed Web of Science ®Google Scholar
• Sioud M, Sørensen DR. 2003. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun. 312:1220–1225.
   PubMed Web of Science ®Google Scholar
• Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. 2003. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 5:834–839.
   PubMed Web of Science ®Google Scholar
• Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, et al. 2004. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature. 432:173–178.
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. 2005. Toll-like receptors in innate immunity. Int Immunol. 17:1–14.
   PubMed Web of Science ®Google Scholar
• Tuschl T. 2001. RNA interference and small interfering RNAs. Chembiochem. 2:239–245.
   PubMed Web of Science ®Google Scholar
• Tuschl T, Borkhardt A. 2002. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol Intervent. 2:158.
   PubMedGoogle Scholar
• Uchida T, Scumpia P, Moldawer L. 2006. Variable requirement of dendritic cells for recruitment, but not activation, of NK and T cells to different TLR agonists. Shock. 25:80.
   PubMed Web of Science ®Google Scholar
• Verthelyi D, Zeuner RA. 2003. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 24:519–522.
   PubMed Web of Science ®Google Scholar
• Williams BR. 2001. Signal integration via PKR. Sci STKE. 2001:re2.
   PubMedGoogle Scholar
• Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 5:730–737.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Weinschenk T, Guo K, Schluesener HJ. 2006. siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J Cell Biochem. 97:1217–1229.
   PubMed Web of Science ®Google Scholar